Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal.

MLA

Silva Miguel, Luís, et al. “Cost-Effectiveness of Semaglutide 2.4 Mg in Chronic Weight Management in Portugal.” Diabetology & Metabolic Syndrome, vol. 16, no. 1, Apr. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13098-024-01338-4.

APA

Silva Miguel, L., Soares, M., Olivieri, A., Sampaio, F., Lamotte, M., Shukla, S., Conde, V., Freitas, P., Costa, J., & Borges, M. (2024). Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal. Diabetology & Metabolic Syndrome, 16(1), 1–11. https://doi.org/10.1186/s13098-024-01338-4

Chicago

Silva Miguel, Luís, Mariana Soares, Anamaria Olivieri, Filipa Sampaio, Mark Lamotte, Suramya Shukla, Vasco Conde, Paula Freitas, João Costa, and Margarida Borges. 2024. “Cost-Effectiveness of Semaglutide 2.4 Mg in Chronic Weight Management in Portugal.” Diabetology & Metabolic Syndrome 16 (1): 1–11. doi:10.1186/s13098-024-01338-4.